The trial aims to estimate the efficacy and safety of the intracoronary administration of
adrenalin, verapamil, as well as their combination compared to standard treatment in patients
with STEMI and refractory coronary no-reflow despite conventional treatment during
percutaneous coronary intervention (PPCI)
Phase:
N/A
Details
Lead Sponsor:
Tomsk National Research Medical Center of the Russian Academy of Sciences